Mutational analysis of designed peptides that undergo structural transition from α helix to β sheet and amyloid fibril formation

Structure

Volumn 8, Issue 9, 2000, Pages 915-925

  Takahashi, Yuta ^a   Ueno, Akihiko ^a   Mihara, Hisakazu ^a,b  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Amino acid substitution; Amyloid fibril; Complementary assembly; De novo design; Peptide; structural transition

Indexed keywords

ALANINE; AMYLOID; GLUTAMINE; MUTANT PROTEIN;

ALPHA HELIX; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; MUTATION; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; STRUCTURE ANALYSIS;

EID: 0034665227     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(00)00183-0     Document Type: Article

References (64)

1. Protein aggregation: Folding aggregates, inclusion bodies and amyloid
2. Protein misfolding, evolution and disease
3. Amyloid fibrillogenesis: Themes and variations
4. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways
5. Conformational changes and diseases - Serpins, prions and Alzheimer's
6. Engineering peptides and proteins that undergo α-to-β transitions
7. Design of peptides undergoing self-catalytic α-to-β transition and amyloidogenesis
8. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
9. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
10. Translating cell biology into therapeutic advances in Alzheimer's disease
11. Solution structure of amyloid β-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
12. Solution structures of micelle-bound amyloid β-(1-40) and β-(1-42) peptides of Alzheimer's disease
13. Prions
14. Protein design: A hierarchic approach
15. De novo design and structural characterization of proteins and metalloproteins
16. Amphiphilic secondary structure: Design of peptide hormones
17. Templates that induce α-helical, β-sheet, and loop conformations
18. Minimal model systems for β sheet secondary structure in proteins
19. Nucleated antiparallel β-sheet that folds and undergoes self-assembly: A template promoted folding strategy toward controlled molecular architectures
20. De novo amyloid proteins from designed combinatorial libraries
21. β-Helical fibrils from a model peptide
22. Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes
23. Direct conversion of an oligopeptide from a β-sheet to an α-helix: A model for amyloid formation
24. Peptides as conformational switch: Medium-induced conformational transitions of designed peptides
25. Super-secondary structure with amphiphilic β-strands probed by pyrenylalanine
26. Switch peptides: pH-induced α-helix to β-sheet transitions of bis-amphiphilic oligopeptides
27. Conformational switching in designed peptides: The helix/sheet transition
28. Redox-triggered secondary structure changes in the aggregated states of a designed methionine-rich peptide
29. Regulation of α/β-folding of a designed peptide by haem binding
30. Context-dependent secondary structure formation of a designed protein sequence
31. Transmuting α helices and β sheets
32. Evolution of a protein fold in vitro
33. α→β Transition of β-lactoglobulin as evidenced by heteronuclear NMR
34. Design of a peptide undergoing α-β structural transition and amyloid fibrillogenesis by the introduction of a hydrophobic defect
35. Optimization of hydrophobic domains in peptides that undergo transformation from α-helix to β-fibril
36. Construction of peptides that undergo structural transition from α-helix to β-sheet and amyloid fibril formation by the introduction of N-terminal hydrophobic amino acids
37. De novo design of α-helical coiled-coils and bundles: Models for the development of protein-design principles
38. Determination of protein secondary structure by Fourier transform infrared spectroscopy: A critical assessment
39. Physical morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ
40. X-ray diffraction of scrapie prion rods and PrP peptides
41. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution
42. β-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
43. Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide
44. 10-35) is parallel β-sheet with residues in exact resister
45. Common core structure of amyloid fibrils by synchrotron X-ray diffraction
46. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing
47. An atomic model for the pleated β-sheet structure of Aβ amyloid protofilaments
48. Amyloid fibril formation by an SH3 domain
49. Designing conditions for in vitro formation of amyloid protofilaments and fibrils
50. Conformational self replication of peptide: Conversion from α-helix to β-fibril of designed coiled-coil peptide
51. Mutation of Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type
52. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation
53. A simple method for displaying the hydropathic character of a protein
54. The D178N (cis-129M) 'fatal familial insomnia' mutation associated with diverse clinicopathologic phenotypes in an Australian kindred
55. Increased body temperature accelerates aggregation of the Leu-68 → Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy
56. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion
57. +], a heritable prion-like factor of S. cerevisiae
58. Glutamine repeats and neurodegenerative diseases: Molecular aspects
59. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
60. The glutamine-rich domain of the Drosophila GAGA factor is necessary for amyloid fibre formation in vitro, but not for chromatin remodelling
61. Deprotection of the S-trimethylacetamidomethyl (Tacm) group using silver tetrafluoroborate: Application to the synthesis of porcine brain natriuretic peptide-32 (pBNP-32)
62. Disulfide bond formation in S-acetamidomethyl cysteine-containing peptides by the combination of silver trifluoromethanesulfonate and dimethylsulfoxide/aqueous HCl
63. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl α-chymotrypsin using different denaturants